• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用骨髓浓缩物和牙髓干细胞治疗下颌骨放射性骨坏死。

Treatment of osteoradionecrosis of mandible with bone marrow concentrate and with dental pulp stem cells.

作者信息

Manimaran K, Sankaranarayanan S, Ravi V R, Elangovan S, Chandramohan M, Perumal S Mahendra

机构信息

Department of Oral and Maxillofacial Surgery, K.S.R. Institute of Dental Science and Research, Tiruchengode, India.

Director, Mothercell Regenerative Centre, Trichy, Tamil Nadu, India.

出版信息

Ann Maxillofac Surg. 2014 Jul-Dec;4(2):189-92. doi: 10.4103/2231-0746.147130.

DOI:10.4103/2231-0746.147130
PMID:25593871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4293842/
Abstract

Osteoradionecrosis (ORN) is a noninfectious, necrotic condition of the bone occurring as a complication of radiotherapy. Most cases occur following trauma or surgical manipulation of the irradiated site. Mandible is the most common bone to be affected following head and neck irradiation. The aim was to develop a successful therapeutic approach for ORN. A spectrum of treatment modalities is practiced for ORN with variable success rate that includes simple irrigation of the affected bone to the partial or complete resection of the jaw bone. In this paper, we present two cases which had successful therapeutic approach for ORN of mandible with autologous bone marrow concentrate stem cells and allogeneic dental pulp stem cells (DPSC) with platelet rich plasma (PRP) following failure of conventional methods. Autologous bone marrow aspirate concentrate (BMAC) was injected around the socket and into the periosteum for one case, and DPSC were mixed with tricalcium phosphate and inserted at the site of the defect in one case. The patient treated with BMAC remained asymptomatic and complete bone remodeling was noticed after 1 year. The extraoral sinus was excised, and healing was uneventful without recurrence in the patient treated with allogeneic DPSC and PRP. Periodic panoramic radiographs revealed an appreciable bone formation from the 2(nd) month onward. We have successfully treated two cases of ORN with BMAC and DPSC, respectively.

摘要

放射性骨坏死(ORN)是一种非感染性的骨坏死疾病,是放疗的并发症。大多数病例发生在受照射部位受到创伤或进行手术操作之后。下颌骨是头颈部放疗后最常受影响的骨骼。目的是开发一种成功治疗ORN的方法。针对ORN采用了一系列治疗方式,成功率各不相同,包括对受影响骨骼进行简单冲洗到颌骨的部分或完全切除。在本文中,我们介绍了两例下颌骨ORN患者,在传统方法治疗失败后,分别采用自体骨髓浓缩干细胞和异体牙髓干细胞(DPSC)联合富血小板血浆(PRP)成功治疗。其中一例将自体骨髓抽吸浓缩物(BMAC)注射到牙槽窝周围和骨膜内,另一例将DPSC与磷酸三钙混合后植入缺损部位。接受BMAC治疗的患者无症状,1年后观察到完全的骨重塑。接受异体DPSC和PRP治疗的患者,切除口外窦道后愈合顺利,无复发。定期全景X线片显示从第2个月起有明显的骨形成。我们分别用BMAC和DPSC成功治疗了两例ORN患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d41/4293842/b5ac601abad3/AMS-4-189-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d41/4293842/046923916f86/AMS-4-189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d41/4293842/a08c62c96a84/AMS-4-189-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d41/4293842/b5ac601abad3/AMS-4-189-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d41/4293842/046923916f86/AMS-4-189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d41/4293842/a08c62c96a84/AMS-4-189-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d41/4293842/b5ac601abad3/AMS-4-189-g008.jpg

相似文献

1
Treatment of osteoradionecrosis of mandible with bone marrow concentrate and with dental pulp stem cells.采用骨髓浓缩物和牙髓干细胞治疗下颌骨放射性骨坏死。
Ann Maxillofac Surg. 2014 Jul-Dec;4(2):189-92. doi: 10.4103/2231-0746.147130.
2
Osseous Tissue Engineering in the Management of Mandibular Osteoradionecrosis - An Evaluative Study.骨组织工程在治疗下颌骨放射性骨坏死中的应用——一项评估性研究
Ann Maxillofac Surg. 2023 Jan-Jun;13(1):19-25. doi: 10.4103/ams.ams_164_22. Epub 2023 Mar 27.
3
Regeneration of mandibular osteoradionecrosis defect with platelet rich plasma gel.富血小板血浆凝胶再生下颌骨放射性骨坏死缺损。
In Vivo. 2010 Nov-Dec;24(6):889-93.
4
Osteogenic potential of effective bone engineering using dental pulp stem cells, bone marrow stem cells, and periosteal cells for osseointegration of dental implants.利用牙髓干细胞、骨髓干细胞和骨膜细胞构建有效的骨工程以实现种植牙的骨整合的成骨潜力。
Int J Oral Maxillofac Implants. 2011 Sep-Oct;26(5):947-54.
5
[Osteoradionecrosis and dental implants].[放射性骨坏死与牙种植体]
Rev Stomatol Chir Maxillofac. 2008 Dec;109(6):387-91; discussion 391-2. doi: 10.1016/j.stomax.2008.07.008. Epub 2008 Oct 18.
6
Autologous bone marrow aspirate concentrate (BMAC) for treatment of keratocystic odontogenic tumour (KCOT)-a case report.自体骨髓抽吸浓缩物(BMAC)治疗角化囊性牙源性肿瘤(KCOT)——病例报告
Stem Cell Investig. 2021 Aug 16;8:16. doi: 10.21037/sci-2020-059. eCollection 2021.
7
Radiotherapy-induced mandibular bone complications.放射治疗引起的下颌骨并发症。
Cancer Treat Rev. 2002 Feb;28(1):65-74. doi: 10.1053/ctrv.2002.0254.
8
Research Frontiers in Oral Toxicities of Cancer Therapies: Osteoradionecrosis of the Jaws.癌症治疗口腔毒性的研究前沿:颌骨放射性骨坏死
J Natl Cancer Inst Monogr. 2019 Aug 1;2019(53). doi: 10.1093/jncimonographs/lgz006.
9
Analysis of surgical margins in cases of mandibular osteoradionecrosis that progress despite extensive mandible resection and free tissue transfer.分析广泛下颌骨切除和游离组织移植后仍进展的下颌骨放射性骨坏死病例的手术切缘。
Am J Otolaryngol. 2012 Sep-Oct;33(5):576-80. doi: 10.1016/j.amjoto.2012.03.001. Epub 2012 Apr 20.
10
Medical treatment of osteoradionecrosis of the mandible by PENTOCLO: preliminary results.五氯酚治疗下颌骨放射性骨坏死的初步结果
Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Dec;131(6):333-338. doi: 10.1016/j.anorl.2013.11.006. Epub 2014 Jun 30.

引用本文的文献

1
METTL3 promotes immature dental pulp stem cells-induced angiogenesis by regulating ETS1 mRNA stability in an mA-HuR-dependent manner.METTL3通过以mA-HuR依赖的方式调节ETS1 mRNA稳定性来促进未成熟牙髓干细胞诱导的血管生成。
Odontology. 2025 Jan;113(1):305-317. doi: 10.1007/s10266-024-00977-3. Epub 2024 Jul 5.
2
Mesenchymal Stromal Cells Derived from Dental Tissues: Immunomodulatory Properties and Clinical Potential.牙髓组织来源的间充质基质细胞:免疫调节特性和临床潜能。
Int J Mol Sci. 2024 Feb 6;25(4):1986. doi: 10.3390/ijms25041986.
3
Osseous Tissue Engineering in the Management of Mandibular Osteoradionecrosis - An Evaluative Study.

本文引用的文献

1
Adipose stem cells used to reconstruct 13 cases with cranio-maxillofacial hard-tissue defects.用脂肪干细胞重建了 13 例颅颌面硬组织缺损。
Stem Cells Transl Med. 2014 Apr;3(4):530-40. doi: 10.5966/sctm.2013-0173. Epub 2014 Feb 20.
2
GMP-level adipose stem cells combined with computer-aided manufacturing to reconstruct mandibular ameloblastoma resection defects: Experience with three cases.GMP级脂肪干细胞联合计算机辅助制造重建下颌骨成釉细胞瘤切除术后缺损:三例经验
Ann Maxillofac Surg. 2013 Jul;3(2):114-25. doi: 10.4103/2231-0746.119216.
3
Three years after transplants in human mandibles, histological and in-line holotomography revealed that stem cells regenerated a compact rather than a spongy bone: biological and clinical implications.
骨组织工程在治疗下颌骨放射性骨坏死中的应用——一项评估性研究
Ann Maxillofac Surg. 2023 Jan-Jun;13(1):19-25. doi: 10.4103/ams.ams_164_22. Epub 2023 Mar 27.
4
Clinical trials using dental stem cells: 2022 update.使用牙干细胞的临床试验:2022年更新
World J Stem Cells. 2023 Mar 26;15(3):31-51. doi: 10.4252/wjsc.v15.i3.31.
5
Autologous bone marrow aspirate concentrate (BMAC) for treatment of keratocystic odontogenic tumour (KCOT)-a case report.自体骨髓抽吸浓缩物(BMAC)治疗角化囊性牙源性肿瘤(KCOT)——病例报告
Stem Cell Investig. 2021 Aug 16;8:16. doi: 10.21037/sci-2020-059. eCollection 2021.
6
CD146 controls the quality of clinical grade mesenchymal stem cells from human dental pulp.CD146 控制着人类牙髓来源的临床级间充质干细胞的质量。
Stem Cell Res Ther. 2021 Aug 30;12(1):488. doi: 10.1186/s13287-021-02559-4.
7
Cross-Talk Between Mesenchymal Stromal Cells (MSCs) and Endothelial Progenitor Cells (EPCs) in Bone Regeneration.间充质基质细胞(MSCs)与内皮祖细胞(EPCs)在骨再生中的相互作用
Front Cell Dev Biol. 2021 May 13;9:674084. doi: 10.3389/fcell.2021.674084. eCollection 2021.
8
The Particle Radiobiology of Multipotent Mesenchymal Stromal Cells: A Key to Mitigating Radiation-Induced Tissue Toxicities in Cancer Treatment and Beyond?多能间充质基质细胞的粒子放射生物学:减轻癌症治疗及其他领域辐射诱导组织毒性的关键?
Front Oncol. 2021 Apr 12;11:616831. doi: 10.3389/fonc.2021.616831. eCollection 2021.
9
Leukocyte- and platelet-rich fibrin does not provide any additional benefit for tooth extraction in head and neck cancer patients post-radiotherapy: a randomized clinical trial.富含白细胞和血小板的纤维蛋白在头颈部癌症患者放疗后拔牙中不提供任何额外益处:一项随机临床试验。
Med Oral Patol Oral Cir Bucal. 2020 Nov 1;25(6):e799-e804. doi: 10.4317/medoral.23804.
10
Leukocyte- and platelet-rich fibrin as an adjuvant to the surgical approach for osteoradionecrosis: a case report.富含白细胞和血小板的纤维蛋白作为放射性骨坏死手术治疗的辅助手段:一例报告
J Korean Assoc Oral Maxillofac Surg. 2020 Apr 30;46(2):150-154. doi: 10.5125/jkaoms.2020.46.2.150.
人类下颌骨移植三年后,组织学和在线全层析成像显示干细胞再生了致密骨而非海绵骨:生物学和临床意义。
Stem Cells Transl Med. 2013 Apr;2(4):316-24. doi: 10.5966/sctm.2012-0136. Epub 2013 Mar 15.
4
Osteogenic potential of effective bone engineering using dental pulp stem cells, bone marrow stem cells, and periosteal cells for osseointegration of dental implants.利用牙髓干细胞、骨髓干细胞和骨膜细胞构建有效的骨工程以实现种植牙的骨整合的成骨潜力。
Int J Oral Maxillofac Implants. 2011 Sep-Oct;26(5):947-54.
5
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw.自体骨髓干细胞病灶内移植修复双膦酸盐相关性颌骨骨坏死。
Head Face Med. 2011 Aug 17;7:16. doi: 10.1186/1746-160X-7-16.
6
Clinico-therapeutic management of osteoradionecrosis: a literature review and update.骨放射性坏死的临床治疗管理:文献回顾与更新。
Med Oral Patol Oral Cir Bucal. 2011 Nov 1;16(7):e900-4. doi: 10.4317/medoral.17257.
7
Improvement of cardiac function by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction.经冠状动脉内移植新鲜分离的骨髓细胞改善急性心肌梗死患者的心功能。
Circ J. 2011;75(3):683-91. doi: 10.1253/circj.cj-10-0817. Epub 2011 Jan 24.
8
Regenerative facial reconstruction of terminal stage osteoradionecrosis and other advanced craniofacial diseases with adult cultured stem and progenitor cells.利用成人培养的干细胞和祖细胞进行终末期放射性骨坏死和其他先进颅面疾病的再生面部重建。
Plast Reconstr Surg. 2010 Nov;126(5):1699-1709. doi: 10.1097/PRS.0b013e3181f24164.
9
In vivo comparison of hard tissue regeneration with human mesenchymal stem cells processed with either the FICOLL method or the BMAC method.应用 FICOLL 法或 BMAC 法处理的人骨髓间充质干细胞在硬组织再生方面的体内比较。
Tissue Eng Part C Methods. 2010 Apr;16(2):215-23. doi: 10.1089/ten.TEC.2009.0269.
10
Instant stem cell therapy: characterization and concentration of human mesenchymal stem cells in vitro.即时干细胞疗法:人骨髓间充质干细胞的体外特性与浓缩
Eur Cell Mater. 2008 Oct 23;16:47-55. doi: 10.22203/ecm.v016a06.